ARCA:SURI

Simplify Propel Opportunities ETF

$ 14.8835 -0.0965 ( -0.64%) 10:24 AM EST
PE Ratio:
51.94
PB Ratio:
0.48
Volume:
278.00
Dividend Yield %:
18.28
Last Holding update 2025-06-23 19 Stocks (2 new)
Value $63.00 Mil Turnover 8 %
Top Holdings: PAGP(42.81%) AKRO(9.28%) MDGL(8.50%) PHAT(6.74%) APLT(6.46%)
Portfolio Report
Registrant: Simplify Propel Opportunities ETF
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Performance Chart Fundamental Charts Technical Indicators Gurus Trades Top Holdings Sector Breakdowns Holding History Back to Top

Simplify Propel Opportunities ETF Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Simplify Propel Opportunities ETF Key Statistics

Name Value
Day's Open ($) 14.88
Day's Range ($) 14.88 - 14.8835
Day's Volume 278
52-Week Range ($) 12.71 - 27.52
Beta -
3-Year Sharpe Ratio -
3-Year Sortino Ratio -
Volatility 35.71
14-Day RSI 36.74
14-Day ATR ($) 0.296428
20-Day SMA ($) 15.778675

Fundamental Data

Name Value
Market Cap (Mil $) 64.879
Shares Outstanding (Mil) 4.36
PE Ratio 51.94
PE Ratio (10y Range) 2.32 - 51.94
PE Ratio (10y Median) 7.76
PB Ratio 0.48
PB Ratio (10y Range) 0.03 - 1.47
PB Ratio (10y Median) 0.25

Dividend Data

Name Value
Dividends per Share (TTM) ($) 2.72
Dividend Yield % 18.28
Dividend Yield % (10y Range) 4.26 - 24.49
Dividend Yield % (10y Median) 13.31
Next Dividend Payment Date
Dividend Frequency Quarterly

SURI Simplify Propel Opportunities ETF Fundamental Charts

Historical TTM Price-to-Earnings for SURI Simplify Propel Opportunities ETF

Historical TTM Price-to-Earnings without NRI for SURI Simplify Propel Opportunities ETF

Historical Price-to-Book Ratio for SURI Simplify Propel Opportunities ETF

Historical Dividend Yields for SURI Simplify Propel Opportunities ETF

Simplify Propel Opportunities ETF Technical Indicators

Moving Average

Momentum

Gurus Latest Trades with ARCA:SURI

No Available Data

ARCA:SURI is held by these investors

No Available Data
Simplify Propel Opportunities ... Top Holdings of 2025-03-31 View Full List
Ticker
Company
Shares
Value ($1000)
Shares Change %
Weighting %
Trade Impact %
% of Shares outstanding
3M Change %
YTD Change %
Market Cap $Mil
Industry
PAGP
Plains GP Holdings LP
1,272,360
27,177.6
0%
42.810
0%
0.640
+11.01%
+8.89%
3,810.5
Oil & Gas
AKRO
Akero Therapeutics Inc
145,609
5,894.3
-36.26%
9.280
-3.45%
0.180
+43.23%
+85.19%
4,107.0
Biotechnology
MDGL
Madrigal Pharmaceuticals Inc
16,294
5,397.1
-30.05%
8.500
-3.23%
0.070
-6.88%
-6.29%
6,420.5
Biotechnology
PHAT
Phathom Pharmaceuticals Inc
681,935
4,275.7
+17.18%
6.740
+0.99%
0.980
+77.82%
+6.65%
604.6
Biotechnology
APLT
Applied Therapeutics Inc
4,101,941
4,101.9
+45.59%
6.460
+2.02%
2.900
-18.15%
-60.80%
47.5
Biotechnology
RNA
Avidity Biosciences Inc
125,000
3,690.0
0%
5.810
0%
0.100
+13.03%
-0.96%
3,471.0
Biotechnology
APLT
Applied Therapeutics Inc
4,487,505
2,193.9
0%
3.460
0%
3.170
-18.15%
-60.80%
47.5
Biotechnology
ABEO
Abeona Therapeutics Inc
408,584
1,944.9
0%
3.060
0%
0.800
+27.64%
+3.23%
294.2
Biotechnology
DCTH
Delcath Systems Inc
117,000
1,489.4
+588.24%
2.350
+2.01%
0.340
+12.19%
+1.66%
426.3
Medical Devices & Instruments
SNDX
Syndax Pharmaceuticals Inc
120,000
1,474.2
0%
2.320
0%
0.140
-20.71%
-33.96%
751.2
Biotechnology

Simplify Propel Opportunities ETF's Historical Top Holdings Breakdowns

Simplify Propel Opportunities ETF's Top Stock Picks View Full List
Ticker
Company
Date
Action
Impact %
Price Range
Price
Price Change from Avrg%
Comment
Current Shares
Share Change
ARDX
Ardelyx Inc
2025-03-31
Sold Out
Sold Out
-5.23%
●
4.91 ($5.37) 6.42
$4.35
-18.99%
Sold Out
0
-689,364
KYMR
Kymera Therapeutics Inc
2025-03-31
Sold Out
Sold Out
-3.71%
●
27.37 ($36.45) 44.36
$43.81
20.19%
Sold Out
0
-2,480,649
AKRO
Akero Therapeutics Inc
2025-03-31
Reduce
Reduce
-3.45%
●
21.87 ($42.39) 57.56
$51.52
21.54%
Reduce -36.26%
145,609
-82,845
MDGL
Madrigal Pharmaceuticals Inc
2025-03-31
Reduce
Reduce
-3.23%
●
272.79 ($328.59) 355.88
$289.17
-12.00%
Reduce -30.05%
16,294
-7,000
APLT
Applied Therapeutics Inc
2025-03-31
Add
Add
+2.02%
●
0.46 ($0.59) 0.94
$0.34
-43.12%
Add 45.59%
4,101,941
1,284,436
DCTH
Delcath Systems Inc
2025-03-31
Add
Add
+2.01%
●
11.48 ($14.19) 16.45
$12.24
-13.74%
Add 588.24%
117,000
100,000
XPAR:MAAT
Maat Pharma SA
2025-03-31
Add
Add
+1.74%
●
5.66 (€7.08) 9.08
€5.06
-28.53%
Add 5181.59%
166,423
163,272
MIST
Milestone Pharmaceuticals Inc
2025-03-31
New Buy
New Buy
+1.07%
●
0.8 ($1.99) 2.41
$2.17
9.05%
New holding
850,000
850,000
KURA
Kura Oncology Inc
2025-03-31
Sold Out
Sold Out
-1.04%
●
6.6 ($7.79) 9.05
$5.68
-27.09%
Sold Out
0
-80,000
PHAT
Phathom Pharmaceuticals Inc
2025-03-31
Add
Add
+0.99%
●
4.22 ($6.07) 7.74
$8.66
42.67%
Add 17.18%
681,935
100,000

Simplify Propel Opportunities ETF Total Holding History ($B)

To

Simplify Propel Opportunities ETF's Asset Allocation

To

Simplify Propel Opportunities ETF Past Portfolios

Portfolio Date Number of Stocks New Stocks Total Value ($Mil) Q/Q Turnover

Top Ranked Articles

  • 1

Simplify Propel Opportunities ETF's Hypothetical Growth since 2025-03-31

Simplify Propel Opportunities ETF's Yearly Returns

Year Portfolio % % Excess Gain %

Simplify Propel Opportunities ETF's Holdings Heat Map

Size field:

Simplify Propel Opportunities ETF's Holdings Bubble Chart

Simplify Propel Opportunities ETF News

  • 1

Discussions on Simplify Propel Opportunities ETF

User's Avatar
How would you rate this stock? SURI
No discussions yet.
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2025 GuruFocus.com, LLC. All Rights Reserved.